CoImmune, Inc.
Industry
- Biotechnology
- Gene Therapy, Cell Therapy
- Pharmaceuticals
See more in Biomedtracker
Latest on CoImmune, Inc.
Scrip
• By Joseph Haas
Athenex Taps NCI TCRs For Solid Tumor Off-The-Shelf Therapy Athenex, Inc. announced a licensing agreement on 9 November with the US National Cancer Institute (NCI) to expand its development capabil
Scrip
• By Ian Haydock, Jung Won Shin, and Joseph Haas
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Astellas Advances IO Ambitions With Two